期刊文献+

2-甲基萘[2,3-b]呋喃-4,9-酮(FNQ3)对肺腺癌细胞株(A549)细胞Fas受体表达和细胞凋亡的影响 被引量:1

Effect of FNQ3 on Fas Receptor Expression and Apoptosis in Lung Adenocarcinoma Cell A549
下载PDF
导出
摘要 目的探讨2-甲基萘[2,3-b]呋喃-4,9-酮(FNQ3)对A549细胞表面Fas受体表达和细胞凋亡的调节效应。方法给A549细胞投与FNQ3,从药物的浓度依赖性及投药的时间依赖性两方面来观察药物对A549细胞表面Fas受体表达及诱导凋亡的作用。用半定量RT-PCR法检测FasmRNA,用流式细胞仪检测A549细胞表面的Fas受体表达和细胞凋亡。结果A549细胞表面Fas受体表达和A549细胞FasmRNA及细胞凋亡敏感度都随着药物浓度和投药时间的增加而增加。在研究药物浓度依赖性时,FNQ3浓度为2.5μg/ml时FasmRNA产量相对较高,为75000分子/μl;A549细胞表面Fas受体表达相对较多;细胞凋亡率达到37.26%(P<0.01)。在研究药物时间依赖性时,FNQ3(0.5μg/ml)投药时间为7天时,FasmRNA产量相对较高,为150000分子/μl;A549细胞表面Fas受体表达相对较多;细胞凋亡率30.45%(P<0.02)。结论FNQ3作为1种抗肿瘤药物能够诱导A549肿瘤细胞表面Fas受体表达,并上调由Fas受体介导的细胞凋亡。 Objective To study the effect of 2-Methylnaphtho[2,3-b]furan-4,9-dione(FNQ3) on Fas receptor expression and apoptosis in A549 cells.Methods The A549 cells were treated with different dose of FNQ3 for 24 hours.Also,the A549 cells received 0.5 g/ml FNQ3 for 1,2,3,7 days.The Fas mRNA was detected by QRT-PCR and the cell surface Fas receptor expression and apoptosis were analyzed using flow cytometry.Results FNQ3 increased Fas mRNA product,the expression of Fas receptor and apoptosis in a dose- and time-dependent manner.With the treatment of highest dose of FNQ(32.5 g/ml),the Fas mRNA Product in A549 cells was 75 000 molecules/μl,the expression of Fas receptor increased and the apoptosis rate reached 37.26%(P<0.01).After the treatment of 0.5 g/ml FNQ3 for 7 days,the Fas mRNA(150 000 molecules/μl),cell surface Fas receptor expression,and apoptosis rate(30.45%) reached the peak(P<0.02).Conclusion FNQ3 can increase the cell surface Fas receptor expression and up-regulate the sensitivity of Fas-mediated apoptosis in a time- and dose-dependent manner.FNQ3 can be used as anti-tumor medicine.
作者 杨萌 林江涛
机构地区 中日友好医院
出处 《实用癌症杂志》 2005年第2期126-130,共5页 The Practical Journal of Cancer
  • 相关文献

参考文献20

  • 1Friesen C,Herr I,Krammer PH,et al.Involvement of the CD95(APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells[J].Nat Med,1996,2(5):574.
  • 2Muller M,Strand S,Hug H,et al.Drug-induced apoptosis in hepatoma cells is mediated by the CD95 8Apo-1/fas) receptor/ligand system and involves activation of wide-type p53[J].J Clin Invest,1997,99(3):403.
  • 3Nagata S,Goldstein P.The Fas death factor[J].Seince,1995,267(5203):1449.
  • 4Fulda S,Sieverts H,Friesen C,et al.The CD95(APO-1/Fas) system mediates drug-induced apoptosis in neuroblastoma cells[J].Cancer Res,1997,57(17):3823.
  • 5Nambu Y,Hughes SJ,Rehemtulla A,et al.Lack of Cell Surface Fas/APO-1 Expression in Pulmonary Adenocarcinomas[J].J Clin Invest,1998,101(5):1102.
  • 6Trauth C,Klas C,Peters AMJ,et al.Monoclonal antibody-mediated tumor regression by induction of apoptosis[J].Science(Washington,DC),1989,245(4915):301.
  • 7Inazawa J,Itoh H,Abe T,et al.Assignment of the human Fas antigen gene(FAS) to 10q24.1[J].Genomics,1992,14(3):821.
  • 8Itoh N,Yonehara S,Ishii A,et al.The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediat apotosis[J].Cell,1991,66(2):233.
  • 9Smith CA,Farrah T,Goodwin RG.The TNF receptor surperfamily of cellular and viral proteins:activation costimulation and death[J].Cell,1994,76(6):959.
  • 10Suda T,Takahashi T,Goldstein P,et al.Molecular cloning and expression of the Fas ligand,a member of the tumor necrosis factor family[J].Cell,1993,75(6):1169.

二级参考文献20

  • 1Devireddy LR, et al.J Virol,1999;73(5):3778-3788
  • 2Nava VE, et al.J Virol,1998;452-459
  • 3Sahara S, et al. Nature,1999;401:168-173
  • 4Rayet B, et al. J Virol,1998;8893-8903
  • 5Dockrell DH, et al.J Clin Invest,1998;101(11):2394-2405
  • 6O'donnell DR, et al. Virology,1999;257(1):198-207
  • 7Fujimoto I, et al. 1998;5(5):426-431
  • 8Gomez del Moral M, et al.J Virol,1999;73(3):2173-2180
  • 9Hofman P, et al.J Leu Bio,1997;61:408-414
  • 10Su Fei, et al. Proc Natl Acad Sci. USA1997;94:8744-8749

共引文献6

同被引文献14

引证文献1

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部